Skip to main content

Table 2 Quantitative improvement of respiratory parameters in 39 rhinitic patients and in 38 asthmatic patient after drug administration with A3C nebulizer

From: Efficacy and usability of a novel nebulizer targeting both upper and lower airways

 

pre

post

p-valuea

 

mean

SD

mean

SD

 

Rhinitic patients

 Total nasal inspiratory airflow (ml/s)

275

216

359

188

0.030

Asthmatic patients

 FEV 1 (l)

1.59

0.63

1.90

0.80

<0.001

 Tiffeneau index (%)

78

11.0

87

10.1

<0.001

 MMEF 25-75 (l/s)

1.32

0.50

2.01

0.85

<0.001

  1. Quantitative data were summarized as mean and standard deviation (SD)
  2. aA paired t-test, when condition were respected (Shapiro-Wilk test was used to assess normality of data), or Wilcoxon signed-rank test was performed to show differences in time within each group